FABP2 and portal hypertension: Clinically, ALC is usually accompanied by portal hypertension and increased gut permeability, both of which contribute to the accumulation of pathogen‐associated molecules, such as LPS, in the blood circulation.48 In the present study, we found that serum I‐FABP levels, a marker for gut permeability, were significantly increased in ALD patients.